Efficacy of canakinumab for mosaic tumor necrosis factor receptor associated periodic syndrome

Eur J Intern Med. 2024 Feb 1:S0953-6205(24)00041-4. doi: 10.1016/j.ejim.2024.01.034. Online ahead of print.NO ABSTRACTPMID:38307733 | DOI:10.1016/j.ejim.2024.01.034

Source: European Journal of Internal Medicine - February 2, 2024 Category: Internal Medicine Authors: Alexandre Terr é Mathieu Vautier Jean-Emmanuel Kahn Sophie Georgin-Lavialle Guilaine Boursier Source Type: research